Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial
- DOI
- 10.1016/j.ebiom.2022.104322
- Published
- 2022-12
- Container
- eBioMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2022.104322,
title = {Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial},
author = {Nomathemba Chandiwana and Chelsea Kruger and Hilary Johnstone and Mohamed Farouk Chughlay and Chung Ju and Byungsu Kim and Yengiwe Dineka and Sarah Arbe-Barnes and Robert Miller and Andrew Owen and Andrew Hill and Daniel Windgassen and Nada Abla and Anne Claire Marrast and Stephan Duparc and Willem Daniel Francois Venter},
year = {2022},
journal = {eBioMedicine},
doi = {10.1016/j.ebiom.2022.104322},
url = {https://doi.org/10.1016/j.ebiom.2022.104322}
}RIS
TY - JOUR TI - Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial AU - Nomathemba Chandiwana AU - Chelsea Kruger AU - Hilary Johnstone AU - Mohamed Farouk Chughlay AU - Chung Ju AU - Byungsu Kim AU - Yengiwe Dineka AU - Sarah Arbe-Barnes AU - Robert Miller AU - Andrew Owen AU - Andrew Hill AU - Daniel Windgassen AU - Nada Abla AU - Anne Claire Marrast AU - Stephan Duparc AU - Willem Daniel Francois Venter PY - 2022 JO - eBioMedicine DO - 10.1016/j.ebiom.2022.104322 UR - https://doi.org/10.1016/j.ebiom.2022.104322 ER -
APA
Chandiwana, N., Kruger, C., Johnstone, H., Chughlay, M. F., Ju, C., Kim, B., Dineka, Y., Arbe-Barnes, S., Miller, R., Owen, A., Hill, A., Windgassen, D., Abla, N., Marrast, A. C., Duparc, S., & Venter, W. D. F. (2022). Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial. eBioMedicine. https://doi.org/10.1016/j.ebiom.2022.104322
Source records
- crossref · retrieved 2026-09-26T18:22:02.692Z